Questions regarding the safety and duration of immunity following live yellow fever vaccination-Reference-Cited by-同舟云学术

Questions regarding the safety and duration of immunity following live yellow fever vaccination

Published:2016-06-20 Issue:12 Volume:15 Page:1519-1533
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Amanna Ian J.¹,Slifka Mark K.²

Affiliation:

1. Najít Technologies, Inc., Beaverton, OR, USA

2. Division of Neuroscience, Oregon National Primate Research Center, Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Beaverton, OR, USA

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2016.1198259

Reference114 articles.

1. The US‐Certified Yellow Fever Vaccination Center Registry: A Tool for Travelers, State Health Departments, and Vaccine Providers

2. Yellow fever

3. Demographic profile of sylvatic yellow fever in Brazil from 1973 to 2008

4. A randomised double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213/77 in children nine-23 months old

5. Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and immunogenicity of the yellow fever vaccine for patients with end-stage renal disease;Brazilian Journal of Nephrology;2024-12

2. Segurança e imunogenicidade da vacina contra febre amarela para pacientes com doença renal em estágio terminal;Brazilian Journal of Nephrology;2024-12

3. Development of a hydrogen peroxide-inactivated vaccine that protects against viscerotropic yellow fever in a non-human primate model;Cell Reports Medicine;2024-07

4. Humoral immunogenicity of primary yellow fever vaccination in infants and children: a systematic review, meta-analysis and meta-regression;Journal of Travel Medicine;2024-03-04

5. Yellow Fever Reemergence Risk in the Guiana Shield: a Comprehensive Review of Cases Between 1990 and 2022;Current Tropical Medicine Reports;2023-07-18